Progress to Further Commercialisation - updates, page-5

Where is the floor...who knows? This is a highly speculative share and will yo yo in value and movement until further announcements, this is the characteristic of a speculative biotech, we should expect it and wait for an announcement. It does not have the market cap, suite of established tests or sales data to be considered any thing else, but we knew that on purchase and I think we bought potential ....whether that materialises we don't know but we just have to say on the balance of probability at this stage the SP has the potential to increase in the next 12 months